2018年9月28日 · The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) represents a standardized, evidence-based reporting system for salivary gland fine-needle aspiration (FNA). The role of FNA is well established for the preoperative evaluation of patients with salivary gland lesions; however, the lack of a uniform system for salivary gland FNA ...

MSRSGC is a recently proposed six category scheme, which places salivary gland FNAC into well-defined categories that limit the possibilities of false negative and false positive cases. Keywords: Fine-needle aspiration cytology, risk of malignancy, salivary …

2024年1月1日 · The second edition of the Milan System for Reporting Salivary Gland Cytopathology, published in July 2023, includes refined risks of malignancy based on systematic reviews and meta-analyses, a new chapter summarizing the use of salivary gland imaging, new advances in ancillary testing, updates in nomenclature, and a guide to the practical ...

The six categories of Milan system were as follows – Category I (Non-diagnostic), Category II (Non-neoplastic), Category III (Atypia of Undetermined Significance [AUS]), Category IVa (benign), Category IVb (Salivary gland neoplasm of Uncertain Malignant Potential [SUMP]), Category V (Suspicious for Malignancy [SFM]), and Category VI (Malignant).

2024年7月1日 · What Is the Milan System for Reporting Salivary Gland Cytopathology? Similar to the Bethesda system for thyroid lesions, the MSRSGC includes a tiered categorical framework for reporting FNA findings of salivary gland lesions.

In the Milan system for reporting salivary gland cytology, the category of neoplasm has been subdivided into two distinct groups: (a) benign and (b) SG neoplasm of uncertain malignant potential (SUMP). 10,27 Nonetheless, the general expectation for management of the two categories is based on cross-sectional imaging, followed by tumour ...

The cytological categories based on the Milan reporting system included nondiagnostic (category 1), nonneoplastic (category 2), atypia of undetermined significance (AUS) (category 3), benign neoplasm (category 4a), neoplasm of uncertain malignant potential (NUMP, category 4b), suspicious for malignancy (category 5), and malignant (category 6).

2018年5月1日 · The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) is designed to include best practice guidelines pertaining to SG-FNA including: 1) indications for SG-FNA, 2) a standard FNA technique, 3) standardized reporting of results for SG-FNA, and 4) the application of ancillary techniques, including immunochemistry and molecular ...

The Milan System for Reporting Salivary Gland Cytopathology 2nd Edition represents an essential step towards increasing the overall effectiveness of salivary gland FNA and fostering better communication between clinicians and between institutions to improve overall patient care.

The MSRSGC defines six diagnostic fine-needle aspiration categories encompassing the spectrum of Non-Neoplastic, benign, and malignant lesions of the salivary glands. The goal of the MSRSGC is to combine each diagnostic category with a defined risk of malignancy and a specific clinical and/or surgical management algorithm.